Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Intracranial Germ Cell Tumor”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 10 of 0 results

Early research (Phase 1)Not Yet RecruitingNCT07444606
What this trial is testing

Dose Ranging, Toxicity Seeking, Phase 1 Trial of Oncolytic Adenoviral Therapy for Melanoma Intracranial and Extracranial Metastases

Who this might be right for
Melanoma
M.D. Anderson Cancer Center 50
Testing effectiveness (Phase 2)Study completedNCT02039947
What this trial is testing

Study to Evaluate Treatment of Dabrafenib Plus Trametinib in Subjects With BRAF Mutation-Positive Melanoma That Has Metastasized to the Brain

Who this might be right for
Melanoma and Brain Metastases
Novartis Pharmaceuticals 127
Early research (Phase 1)Study completedNCT01119599
What this trial is testing

RO4929097, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Malignant Glioma

Who this might be right for
Acoustic SchwannomaAdult Anaplastic (Malignant) MeningiomaAdult Anaplastic Astrocytoma+26 more
National Cancer Institute (NCI) 22
Early research (Phase 1)Looking for participantsNCT05556473
What this trial is testing

F-Tryptophan PET/CT in Human Cancers

Who this might be right for
Intracranial GliomaMetastatic Brain TumorBreast Cancer+2 more
Barbara Ann Karmanos Cancer Institute 24
Testing effectiveness (Phase 2)WithdrawnNCT01782976
What this trial is testing

Ph II Cilengitide Plus Bevacizumab for Recurrent Glioblastoma (GBM)

Who this might be right for
Glioblastoma
M.D. Anderson Cancer Center
Early research (Phase 1)WithdrawnNCT03990597
What this trial is testing

StrataXRT in Preventing Radiation Dermatitis in Pediatric Patients Undergoing Radiation Therapy to the Brain or Spinal Cord

Who this might be right for
Central Nervous System SarcomaEpendymomaGlioma+4 more
M.D. Anderson Cancer Center
Not applicableStudy completedNCT00777686
What this trial is testing

Measuring Non-Enhancing Glioblastoma Progression

Who this might be right for
Brain TumorGlioblastoma
M.D. Anderson Cancer Center 7
Testing effectiveness (Phase 2)Ended earlyNCT00021229
What this trial is testing

Imatinib Mesylate With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed or Recurrent Glioma

Who this might be right for
Brain and Central Nervous System Tumors
National Cancer Institute (NCI) 85
Not applicableLooking for participantsNCT04278118
What this trial is testing

Hypofractionated Proton Therapy for Benign Intracranial Brain Tumors, the HiPPI Study

Who this might be right for
Grade I MeningiomaGrade II MeningiomaGrade III Meningioma+4 more
Emory University 70
Testing effectiveness (Phase 2)Study completedNCT00973739
What this trial is testing

Lapatinib Study for Children and Adults With Neurofibromatosis Type 2 (NF2) and NF2-Related Tumors

Who this might be right for
Neurofibromatosis 2Vestibular Schwannoma
NYU Langone Health 21